Health Dictionary Find a Doctor

Hypertensive nephropathy overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Overview

Pathophysiology

Pathophysiology

  • In the kidneys, as a result of benign arterial hypertension, hyaline (pink, amorphous, homogeneous material) accumulates in the wall of small arteries and arterioles, leading to thickening of arterial walls and narrowing of the lumens — hyaline arteriolosclerosis. Consequently, tubular atrophy and interstitial fibrosis will occur.
  • Glomerular alterations (smaller glomeruli with different degrees of hyalinization – from mild to severe glomerulosclerosis) and podocyte loss can increase the endothelial permeability and filtration of remaining glomerules, leading to microalbuminuria and development of CKD
  • Some studies suggest a genetic component in the development of hypertensive nephropathy and nephrosclerosis.

Epidemiology and Demographics

Epidemiology and Demographics

  • The incidence rate for hypertensive kidney disease has been increasing gradually over the past three decades.
  • Annually, 25,000 new cases of CKD associated with hypertension, are diagnosed in the US.
  • Hypertension is known as the second leading cause of ESRD.

Diagnosis

Diagnosis

History and Symptoms

History and Symptoms

  • Most of the patients with hypertensive nephropathy have no symptoms until kidney failure occurs.


References

References

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH